annual D&A:
$8.55M+$674.00K(+8.56%)Summary
- As of today (September 17, 2025), FOLD annual depreciation & amortization is $8.55 million, with the most recent change of +$674.00 thousand (+8.56%) on December 31, 2024.
- During the last 3 years, FOLD annual D&A has risen by +$2.34 million (+37.66%).
- FOLD annual D&A is now -3.38% below its all-time high of $8.85 million, reached on December 31, 2020.
Performance
FOLD Depreciation and amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly D&A:
$1.85M+$15.00K(+0.82%)Summary
- As of today (September 17, 2025), FOLD quarterly depreciation & amortization is $1.85 million, with the most recent change of +$15.00 thousand (+0.82%) on June 30, 2025.
- Over the past year, FOLD quarterly D&A has dropped by -$330.00 thousand (-15.12%).
- FOLD quarterly D&A is now -52.29% below its all-time high of $3.88 million, reached on December 31, 2023.
Performance
FOLD quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM D&A:
$7.90M-$330.00K(-4.01%)Summary
- As of today (September 17, 2025), FOLD TTM depreciation & amortization is $7.90 million, with the most recent change of -$330.00 thousand (-4.01%) on June 30, 2025.
- Over the past year, FOLD TTM D&A has dropped by -$1.75 million (-18.10%).
- FOLD TTM D&A is now -23.95% below its all-time high of $10.39 million, reached on September 30, 2024.
Performance
FOLD TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
FOLD Depreciation and amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +8.6% | -15.1% | -18.1% |
3 y3 years | +37.7% | +38.8% | +36.6% |
5 y5 years | +79.0% | -9.2% | +22.8% |
FOLD Depreciation and amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +60.0% | -52.3% | +47.3% | -23.9% | +53.1% |
5 y | 5-year | -3.4% | +79.0% | -52.3% | +47.3% | -23.9% | +53.1% |
alltime | all time | -3.4% | +6379.9% | -52.3% | +522.7% | -23.9% | +2556.4% |
FOLD Depreciation and amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $1.85M(+0.8%) | $7.90M(-4.0%) |
Mar 2025 | - | $1.84M(-10.0%) | $8.23M(-3.7%) |
Dec 2024 | $8.55M(+8.6%) | $2.04M(-5.9%) | $8.55M(-17.7%) |
Sep 2024 | - | $2.17M(-0.5%) | $10.39M(+7.7%) |
Jun 2024 | - | $2.18M(+1.3%) | $9.65M(+10.0%) |
Mar 2024 | - | $2.15M(-44.5%) | $8.77M(+11.4%) |
Dec 2023 | $7.87M(+47.4%) | $3.88M(+171.8%) | $7.87M(+48.5%) |
Sep 2023 | - | $1.43M(+9.3%) | $5.30M(+2.8%) |
Jun 2023 | - | $1.31M(+3.9%) | $5.16M(-0.5%) |
Mar 2023 | - | $1.26M(-4.1%) | $5.19M(-2.9%) |
Dec 2022 | $5.34M(-14.0%) | $1.31M(+1.9%) | $5.34M(-3.7%) |
Sep 2022 | - | $1.29M(-3.6%) | $5.55M(-4.0%) |
Jun 2022 | - | $1.33M(-5.5%) | $5.78M(-3.9%) |
Mar 2022 | - | $1.41M(-7.0%) | $6.02M(-3.1%) |
Dec 2021 | $6.21M(-29.8%) | $1.52M(-0.1%) | $6.21M(-14.2%) |
Sep 2021 | - | $1.52M(-3.0%) | $7.24M(-11.9%) |
Jun 2021 | - | $1.57M(-2.3%) | $8.21M(-5.4%) |
Mar 2021 | - | $1.60M(-37.0%) | $8.69M(-1.8%) |
Dec 2020 | $8.85M(+85.3%) | $2.55M(+2.0%) | $8.85M(+13.2%) |
Sep 2020 | - | $2.50M(+22.4%) | $7.81M(+21.5%) |
Jun 2020 | - | $2.04M(+15.6%) | $6.43M(+16.0%) |
Mar 2020 | - | $1.76M(+16.5%) | $5.55M(+16.2%) |
Dec 2019 | $4.78M(+13.3%) | $1.51M(+35.7%) | $4.78M(+7.0%) |
Sep 2019 | - | $1.12M(-3.3%) | $4.46M(+1.0%) |
Jun 2019 | - | $1.15M(+16.4%) | $4.42M(+4.3%) |
Mar 2019 | - | $991.00K(-17.5%) | $4.24M(+0.5%) |
Dec 2018 | $4.22M(+17.3%) | $1.20M(+11.9%) | $4.22M(+2.3%) |
Sep 2018 | - | $1.07M(+10.3%) | $4.12M(+5.7%) |
Jun 2018 | - | $973.00K(+0.4%) | $3.90M(+4.3%) |
Mar 2018 | - | $969.00K(-12.5%) | $3.74M(+4.1%) |
Dec 2017 | $3.59M(+10.8%) | $1.11M(+30.2%) | $3.59M(+5.9%) |
Sep 2017 | - | $850.00K(+4.6%) | $3.39M(-1.3%) |
Jun 2017 | - | $813.00K(-1.2%) | $3.44M(+1.4%) |
Mar 2017 | - | $823.00K(-9.2%) | $3.39M(+4.6%) |
Dec 2016 | $3.24M(+76.9%) | $906.00K(+1.1%) | $3.24M(+11.3%) |
Sep 2016 | - | $896.00K(+16.8%) | $2.91M(+20.8%) |
Jun 2016 | - | $767.00K(+14.0%) | $2.41M(+20.7%) |
Mar 2016 | - | $673.00K(+16.6%) | $2.00M(+9.0%) |
Dec 2015 | $1.83M | $577.00K(+46.1%) | $1.83M(+13.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2015 | - | $395.00K(+11.9%) | $1.62M(+1.3%) |
Jun 2015 | - | $353.00K(-30.5%) | $1.60M(-2.6%) |
Mar 2015 | - | $508.00K(+39.6%) | $1.64M(+6.2%) |
Dec 2014 | $1.55M(-10.0%) | $364.00K(-2.9%) | $1.55M(-2.3%) |
Sep 2014 | - | $375.00K(-5.3%) | $1.58M(-3.3%) |
Jun 2014 | - | $396.00K(-3.9%) | $1.64M(-3.2%) |
Mar 2014 | - | $412.00K(+2.7%) | $1.69M(-1.6%) |
Dec 2013 | $1.72M(+0.8%) | $401.00K(-6.5%) | $1.72M(-1.2%) |
Sep 2013 | - | $429.00K(-4.7%) | $1.74M(+0.4%) |
Jun 2013 | - | $450.00K(+2.5%) | $1.73M(+0.5%) |
Mar 2013 | - | $439.00K(+4.3%) | $1.72M(+1.1%) |
Dec 2012 | $1.71M(+7.6%) | $421.00K(-0.2%) | $1.71M(+4.9%) |
Sep 2012 | - | $422.00K(-4.5%) | $1.63M(+2.7%) |
Jun 2012 | - | $442.00K(+5.2%) | $1.58M(+1.0%) |
Mar 2012 | - | $420.00K(+22.8%) | $1.57M(-1.1%) |
Dec 2011 | $1.58M(-23.0%) | $342.00K(-9.8%) | $1.58M(-8.1%) |
Sep 2011 | - | $379.00K(-11.0%) | $1.72M(-7.1%) |
Jun 2011 | - | $426.00K(-2.7%) | $1.86M(-5.3%) |
Mar 2011 | - | $438.00K(-8.9%) | $1.96M(-4.8%) |
Dec 2010 | $2.06M(-3.5%) | $481.00K(-5.9%) | $2.06M(-3.1%) |
Sep 2010 | - | $511.00K(-3.6%) | $2.12M(-2.3%) |
Jun 2010 | - | $530.00K(-1.1%) | $2.17M(+0.5%) |
Mar 2010 | - | $536.00K(-2.0%) | $2.16M(+1.5%) |
Dec 2009 | $2.13M(+42.8%) | $547.00K(-2.5%) | $2.13M(+4.4%) |
Sep 2009 | - | $561.00K(+8.1%) | $2.04M(+9.5%) |
Jun 2009 | - | $519.00K(+2.8%) | $1.86M(+11.2%) |
Mar 2009 | - | $505.00K(+10.5%) | $1.68M(+12.3%) |
Dec 2008 | $1.49M(+20.7%) | $457.00K(+19.3%) | $1.49M(+10.7%) |
Sep 2008 | - | $383.00K(+15.4%) | $1.35M(+5.3%) |
Jun 2008 | - | $332.00K(+3.4%) | $1.28M(+1.6%) |
Mar 2008 | - | $321.00K(+2.6%) | $1.26M(+1.9%) |
Dec 2007 | $1.24M(+29.9%) | $313.00K(-0.6%) | $1.24M(+33.9%) |
Sep 2007 | - | $315.00K(+1.1%) | $924.00K(+51.7%) |
Jun 2007 | - | $311.60K(+4.8%) | $609.00K(+104.8%) |
Mar 2007 | - | $297.40K | $297.40K |
Dec 2006 | $952.50K(+214.6%) | - | - |
Dec 2005 | $302.80K(+111.3%) | - | - |
Dec 2004 | $143.30K(+8.6%) | - | - |
Dec 2003 | $131.90K | - | - |
FAQ
- What is Amicus Therapeutics, Inc. annual depreciation & amortization?
- What is the all time high annual D&A for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. annual D&A year-on-year change?
- What is Amicus Therapeutics, Inc. quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. quarterly D&A year-on-year change?
- What is Amicus Therapeutics, Inc. TTM depreciation & amortization?
- What is the all time high TTM D&A for Amicus Therapeutics, Inc.?
- What is Amicus Therapeutics, Inc. TTM D&A year-on-year change?
What is Amicus Therapeutics, Inc. annual depreciation & amortization?
The current annual D&A of FOLD is $8.55M
What is the all time high annual D&A for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high annual depreciation & amortization is $8.85M
What is Amicus Therapeutics, Inc. annual D&A year-on-year change?
Over the past year, FOLD annual depreciation & amortization has changed by +$674.00K (+8.56%)
What is Amicus Therapeutics, Inc. quarterly depreciation & amortization?
The current quarterly D&A of FOLD is $1.85M
What is the all time high quarterly D&A for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high quarterly depreciation & amortization is $3.88M
What is Amicus Therapeutics, Inc. quarterly D&A year-on-year change?
Over the past year, FOLD quarterly depreciation & amortization has changed by -$330.00K (-15.12%)
What is Amicus Therapeutics, Inc. TTM depreciation & amortization?
The current TTM D&A of FOLD is $7.90M
What is the all time high TTM D&A for Amicus Therapeutics, Inc.?
Amicus Therapeutics, Inc. all-time high TTM depreciation & amortization is $10.39M
What is Amicus Therapeutics, Inc. TTM D&A year-on-year change?
Over the past year, FOLD TTM depreciation & amortization has changed by -$1.75M (-18.10%)